CPT® Code 84234

A receptor assay is a laboratory test conducted to evaluate the presence of specific hormone receptors on tumor cells, which can indicate the likelihood of a tumor responding to hormone therapy. In the context of breast cancer, the progesterone receptor assay, identified by CPT® Code 84234, specifically assesses whether progesterone receptors are present in breast cancer tissue. Hormone receptors are proteins that bind to hormones circulating in the bloodstream, such as progesterone, and play a crucial role in regulating cell growth and reproduction. The presence of progesterone receptors on breast cancer cells suggests that the tumor may rely on progesterone for its growth and could potentially respond to hormone-based treatments. Conversely, if the breast cancer cells are progesterone receptor negative, it indicates a lower likelihood of response to hormone therapy, which may include treatments that utilize hormones to inhibit tumor growth. Understanding the receptor status of breast cancer is essential for determining the most effective treatment strategy for patients, as it guides the selection of appropriate therapeutic interventions.